Doostzadeh J, Morfin R
Laboratoire de Biotechnologie, Conservatoire National des Arts et Métiers, Paris, France.
J Endocrinol. 1997 Nov;155(2):343-50. doi: 10.1677/joe.0.1550343.
Hydroxylations of pregnenolone (PREG) at the 7 alpha- and 7 beta-positions have been reported in numerous murine tissues and organs and responsible cytochrome P450 (CYP) species await identification. Using thin layer chromatography and gas chromatography-mass spectrometry, we report identification of 7 alpha-hydroxy-PREG and 7 beta-hydroxy-PREG metabolites produced in mouse brain microsome digests and kinetic studies of their production with apparent KM values of 0.5 +/- 0.1 microM and 5.1 +/- 0.6 microM for 7 alpha- and 7 beta-hydroxylation respectively. Investigation of CYP inhibitors and of steroid hormone effects on both 7 alpha- and 7 beta-hydroxylations of PREG showed that: (i) different CYP were involved in 7 alpha- and 7 beta-hydroxylation of PREG because solely 7 alpha-hydroxylation was extensively inhibited by metyrapone, alpha-naphthoflavone, ketoconazole and 3 beta-hydroxysteroids, (ii) CYP 1A2, 2D6, 2B1 and 2B11 were not responsible for 7 alpha- and 7 beta-hydroxylation of PREG because respective specific inhibitors furafylline, quinidine and chloramphenicol triggered no inhibition, (iii) CYP 1A1 was responsible for only part of the 7 beta-hydroxylation of PREG because use of alpha-naphthoflavone, which inhibits specifically CYP 1A1, did not suppress entirely 7 beta-hydroxylation, while ketoconazole, metyrapone and antipyrine, which do not inhibit CYP 1A1, decreased part of the 7 beta-hydroxylation, (iv) 7 alpha-hydroxylation of PREG may be shared with other 3 beta-hydroxysteroids such as isoandrosterone and 5-androstene-3 beta,17 beta-diol which were strong inhibitors, but not with dehydroepiandrosterone which was a non-competitive inhibitor as weak as 3-oxosteroids, and (v) 7 beta-hydroxylation of PREG was not markedly changed by other steroids. Taken together, these findings will be of use for identification of the CYP species responsible for 7 alpha- and 7 beta-hydroxylation of PREG and for studies of their activities in brain.
在众多小鼠组织和器官中均已报道孕烯醇酮(PREG)在7α-和7β-位的羟基化反应,而负责该反应的细胞色素P450(CYP)种类尚待鉴定。我们运用薄层色谱法和气相色谱-质谱联用技术,报告了在小鼠脑微粒体消化产物中鉴定出7α-羟基-PREG和7β-羟基-PREG代谢物,并对其生成进行了动力学研究,7α-和7β-羟基化反应的表观KM值分别为0.5±0.1 microM和5.1±0.6 microM。对CYP抑制剂以及甾体激素对PREG的7α-和7β-羟基化反应的影响进行研究后发现:(i)PREG的7α-和7β-羟基化反应涉及不同的CYP,因为仅7α-羟基化反应会被甲吡酮、α-萘黄酮、酮康唑和3β-羟基甾体广泛抑制;(ii)CYP 1A2、2D6、2B1和2B11不负责PREG的7α-和7β-羟基化反应,因为各自的特异性抑制剂呋拉茶碱、奎尼丁和氯霉素未引发抑制作用;(iii)CYP 1A1仅负责部分PREG的7β-羟基化反应,因为使用特异性抑制CYP 1A1的α-萘黄酮并未完全抑制7β-羟基化反应,而不抑制CYP 1A1的酮康唑、甲吡酮和安替比林则降低了部分7β-羟基化反应;(iv)PREG的7α-羟基化反应可能与其他3β-羟基甾体如异雄酮和5-雄烯-3β,17β-二醇相同,它们是强抑制剂,但与脱氢表雄酮不同,脱氢表雄酮是一种非竞争性抑制剂,其抑制作用与3-氧代甾体一样弱;(v)其他甾体对PREG的7β-羟基化反应无明显影响。综上所述,这些发现将有助于鉴定负责PREG的7α-和7β-羟基化反应的CYP种类,并用于研究它们在脑中的活性。